Salute e Benessere

Interim Report Q1 2024: GN Store Nord delivered organic revenue growth of 5%…

Highlights GN delivered continued execution across the three divisions resulting in 5% organic revenue growth for the GroupThe Hearing division delivered continued market share gains leading to 14% organic revenue growth, resulting in 8.2 percentage point increase in the divisional profit margin supported by synergies and a successful ReSound Nexia roll-outThe Enterprise division continued its relentless commercial execution in a stabilizing market leading to 0% organic revenue growth...
Nasdaq GlobeNewswire
02/05/2024

CARBIOS and Hündgen enter supply agreement for world's first PET biorecycling…

CARBIOS and Hündgen enter supply agreement for world's first PET biorecycling plant From end 2026, Hündgen will supply 15kt/year of post-consumer PET flakes to CARBIOS' first commercial plant Clermont-Ferrand, France, Thursday 2 May 2024 (06.45am CEST) CARBIOS(Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, andHündgen Entsorgungs GmbH & Co. KG(Hündgen), a...
Nasdaq GlobeNewswire
02/05/2024

135th Canton Fair Showcases Cutting-Edge Toys and Baby Products, Drawing Global…

Anhui Cool-baby Science & Technology Development Corporation focuses on integrating innovative technology into baby products for enhanced comfort and safety. Their highlight product at the fair is a smart crib that opens instantly at the push of a button without any assembly required, featuring mother-infant safe A-grade fabrics and a seven-point support design for stability, along with universal wheels to ensure easy mobility. To learn more about the company, click https://goo.su/HHVeTF6…
PR Newswire
02/05/2024

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance…

Right targets, right vectors, right patients, right time Right targets, right vectors, right patients, right time Since incorporation in 2021, Infinitopes has moved swiftly to cement its leadership position in cancer vaccines by overcoming three key challenges in the field. Firstly, using its Precision Immunomics TMantigen discovery technologies, the Company can identify and rank tumour signatures, without prior bias, enabling the accurate selection of novel, synergistic tumour targets...
PR Newswire
02/05/2024

Opioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 |…

Key Takeaways from the Opioid Withdrawal Syndrome Market Report Key Takeaways from the Opioid Withdrawal Syndrome Market Report Discover which therapies are expected to grab the major opioid withdrawal syndrome market share @ Opioid Withdrawal Syndrome Market Report Opioid Withdrawal Syndrome Overview Opioid withdrawal is a set of symptoms that occurs when opioids (such as µ-receptor agonists) are suddenly stopped, their use is reduced, or they are no longer taken for treatment...
PR Newswire
01/05/2024

Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care…

About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
01/05/2024

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

/48th of the aggregate number of shares subject to the award on each monthly anniversary of the grant date thereafter, such that the entire award will be vested as of the fourth anniversary of the grant date, subject to continued employment with the Company. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment...
Nasdaq GlobeNewswire
01/05/2024

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms…

"In the first quarter of 2024, we delivered combined double-digit year-over-year growth from our key growth drivers: Xywav, Epidiolex and Rylaze. We also significantly advanced our zanidatamab program with the completion of the BLA for 2L BTC," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals. "We believe the robust growth in patients benefitting from Xywav underscores the appreciation physicians and patients have for the long-term health benefits of…
PR Newswire
01/05/2024

Koelis Announces New Product Release at AUA 2024 to Offer Innovative AI-Enhanced…

ndto May 5 thto demonstrate its novel capacity integrating AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity ®system enables urologists to perform 3D targeted “fusion biopsy” in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company's unique prostate motion tracking software (OBT Fusion ® ). The compact Koelis Trinity ®system does not require interfaces with either...
Nasdaq GlobeNewswire
01/05/2024

Idorsia increases the consent fee in connection with the proposed restructuring…

Ad hoc announcement pursuant to Art. 53 LR The proposed consent fee will be increased to 8'000'000 Idorsia shares. All other matters as proposed on April 23, 2024, remain unchanged.The bondholder meeting will take place on May 6, 2024, in order to vote on the proposals published on April 23, 2024.Allschwil, Switzerland – May 1, 2024Idorsia Ltd (SIX: IDIA) today announced that in relation to the bondholder meeting for holders of its outstanding convertible bonds maturing on July 17,...
Nasdaq GlobeNewswire
01/05/2024

The geko™ device is now available through the NHS Supply Chain

This listing further expands the supply channels available to the NHS when ordering the geko device - an effective, needed treatment for patients across the UK suffering from hard-to-heal wounds and means that wound care settings, NHS staff, publicly funded organisations and hospitals can now more easily purchase this highly effective therapy. This listing further expands the supply channels available to the NHS when ordering the geko device - an effective, needed treatment for patients…
PR Newswire
01/05/2024

Family and Friends Rejoice in Spring's Arrival with Fresh Finds at the 135th…

Nanjing Kekang Outdoor Products Co., Ltd. exhibits Folding Lounge Chairs with Footrests, Outdoor Three-person Swing, Adjustable Beach Chairs and other products to bring consumers a comfortable and convenient outdoor experience. Among these, the adjustable beach chair, which is made of lighter and stronger aluminum, has adjustable gear and can be carried after folding. It is an ideal choice for camping, hiking and vacation! More detailed information has been introduced on https://goo.su/JmTej…
PR Newswire
01/05/2024

2024 World Digital Health Forum: AI at the Forefront of Healthcare Innovation

A highlight of the Forum was the release of the "Tsinghua Urban Health Index," which provides a comprehensive assessment of health services across 296 Chinese cities, establishing a new benchmark in health metrics to aid governmental and regional health planning. In addition, the "World Digital Health Forum Declaration" was ratified, laying down a robust framework for universal access to healthcare, and underscoring the importance of collaboration, ethical standards, and…
PR Newswire
01/05/2024

Enteral Feeding Devices Market Worth $5.6 billion | MarketsandMarkets™

This report divides the enteral feeding devices market into four segments – type, age group, application, end user and region. This report divides the enteral feeding devices market into four segments – type, age group, application, end user and region. Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035 Browse in-depth TOC on "Enteral Feeding Devices Market" 430 - Tables 200 - Figures 450 - Pages Enteral Feeding Devices...
PR Newswire
01/05/2024

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion…

Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development. Joint research efforts accelerate the discovery of novel therapeutic targets and the translation of scientific findings into clinical applications. Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development. Joint research efforts…
PR Newswire
01/05/2024

Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

VANCOUVER, BC, May 1, 2024 /PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society projects that by 2050, the number of people diagnosed with cancer could rise by 77%. According to experts at last year's annual American Society of Clinical Oncology (ASCO) meeting, a little-known bacteria could be behind the rising rates of cancer in…
PR Newswire
01/05/2024

Medical Sensors Market worth $3.6 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Medical Sensors Market" 160 – Tables70 – Figures230 – Pages Browse in-depth TOC on "Medical Sensors Market" 160 – Tables 70 – Figures 230 – Pages Medical Sensors Market Report Scope: The medical sensors market for hospitals & clinics inAsia Pacificis expected to grow at the highest CAGR during the forecast period. The medical sensors market for hospitals & clinics inAsia Pacificis expected to grow at the highest CAGR during the...
PR Newswire
01/05/2024

3Shape Unveils Unite 3rd Generation: Access TRIOS Scans Anywhere, Anytime

Unite 3rd Generation comes free with TRIOS scanners. As part of Unite 3rd Generation users can also download the 3Shape Unite Cloud App, which enables professionals to manage and securely access cases and scans in the cloud, track case progress, and communicate with labs from any device. Gone are the days of being physically tied to a PC, as dentists can simply add photos and notes for the lab to patient cases from their mobile while on the go. Unite 3rd Generation comes free with TRIOS…
PR Newswire
01/05/2024

Neogen® Petrifilm® Celebrates 40 Years!

Introduced in 1984, Petrifilm eliminates the need for traditional agar preparation, saving time and offering consistent, uniform testing media. Forty years later, Petrifilm has become one of the world's most trusted tests, with over 2.85 billion plates used across more than 60 countries, earning 105+ global validations, certifications, and recognitions.* Introduced in 1984, Petrifilm eliminates the need for traditional agar preparation, saving time and offering consistent, uniform testing…
PR Newswire
01/05/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 1 May 2024– On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the...
Nasdaq GlobeNewswire
01/05/2024

Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

BOSTON and LONDON, May01, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO.Rachelle Jacques will step down as Akari's Chief Executive Officer effective today. Melissa Bradford-Klug will step down as Akari's Chief Operating Officer effective...
Nasdaq GlobeNewswire
01/05/2024

Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for…

Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes in separate Akari press release BOSTON and PLEASANTON, Calif., May01, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX, “Akari”) and Peak Bio Inc. (OTC: PKBO, “Peak”) today announced completion of a joint portfolio prioritization review pursuant to which the combined entity,...
Nasdaq GlobeNewswire
01/05/2024

IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th…

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call. If you are unable to join us live, a recording of the call will be available on our website athttps://investors.imcannabis.com/within 24 hours after the call. Link for the zoom call:https://us02web.zoom.us/webinar/register/WN_4MfaN9x7SLm1B9Zr0Asw8w About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an...
PR Newswire
01/05/2024

ArisGlobal Helps Boehringer Ingelheim Transform Safety Signal Processing by…

LifeSphere Clarity picks up where traditional signal detection ends, providing access to knowledge graphs, association graphs, medical case clustering, and more advanced capabilities to drive better understanding the "why" of safety-relevant occurrences and more efficient and standardized risk management for patient safety and pharmacovigilance teams. LifeSphere Clarity picks up where traditional signal detection ends, providing access to knowledge graphs, association graphs, medical…
PR Newswire
01/05/2024
Altri  Comunicati